We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cellceutix Makes Breakthrough in Cancer Research by Activating p53, the "Guardian Angel of the Human Genome"

Product News   Mar 03, 2011

 
Cellceutix Makes Breakthrough in Cancer Research by Activating p53, the "Guardian Angel of the Human Genome"
FURTHER INFORMATION
 
 
 

Related Product News

ATCC Genome Portal Provides Access to Reference-quality Genomes

Product News

ATCC launches its portal of whole-genome sequences based upon authenticated biological standards.

READ MORE

Industrial Scale Manufacture of Therapeutic Exosomes

Product News

BIA Separations has announced a new solution to help drug-developers overcome critical development bottlenecks in the preparation of exosomes for clinical use.

READ MORE

Tumor Regression with New Antibody-Drug Conjugate

Product News

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), has announced the first data on its lead ADC, IKS01.

READ MORE

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE